SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

UPDATE: H.C. Wainwright Maintains Buy On Karyopharm Therapeutics, Raises Target To $36 Notes 'Xpovio Launch Starts Strong'; 'Topline BOSTON data expected early 2020', 'NDA submission is expected in 2020 if the BOSTON data are positive'

Benzinga · -